Abstract 643: Efficacy and safety comparison of CAR-T and blinatumomab immunotherapy as bridge-to-transplant strategy in relapsed/refractory B cell acute lymphoblastic leukemia
Authors: Wenyue Cao, Ningwen Li, Na Wang, Yang Cao
Published: 2025-04-22
DOI:
10.1158/1538-7445.am2025-643
Source:
Full article
Abstract
Background: